- Home
- RARE vs AWR Comparison
RARE vs AWR Comparison
Compare RARE & AWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RARE
- AWR
- Stock Information
- Founded
- RARE 2010
- AWR 1929
- Country
- RARE United States
- AWR United States
- Employees
- RARE N/A
- AWR N/A
- Industry
- RARE Biotechnology: Pharmaceutical Preparations
- AWR Water Supply
- Sector
- RARE Health Care
- AWR Utilities
- Exchange
- RARE Nasdaq
- AWR Nasdaq
- Market Cap
- RARE 3.3B
- AWR 2.9B
- IPO Year
- RARE 2014
- AWR N/A
- Fundamental
- Price
- RARE $37.17
- AWR $76.66
- Analyst Decision
- RARE Strong Buy
- AWR Sell
- Analyst Count
- RARE 17
- AWR 2
- Target Price
- RARE $92.29
- AWR $77.50
- AVG Volume (30 Days)
- RARE 974.0K
- AWR 202.1K
- Earning Date
- RARE 07-31-2025
- AWR 08-05-2025
- Dividend Yield
- RARE N/A
- AWR 2.43%
- EPS Growth
- RARE N/A
- AWR 5.87
- EPS
- RARE N/A
- AWR 3.24
- Revenue
- RARE $590,689,000.00
- AWR $608,221,000.00
- Revenue This Year
- RARE $18.94
- AWR $9.72
- Revenue Next Year
- RARE $28.93
- AWR $4.03
- P/E Ratio
- RARE N/A
- AWR $23.67
- Revenue Growth
- RARE 33.46
- AWR 6.79
- 52 Week Low
- RARE $29.59
- AWR $69.46
- 52 Week High
- RARE $60.37
- AWR $87.50
- Technical
- Relative Strength Index (RSI)
- RARE 55.64
- AWR 41.59
- Support Level
- RARE $35.73
- AWR $76.44
- Resistance Level
- RARE $36.22
- AWR $79.32
- Average True Range (ATR)
- RARE 1.37
- AWR 1.24
- MACD
- RARE 0.25
- AWR -0.22
- Stochastic Oscillator
- RARE 90.54
- AWR 5.53
About RARE Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.
About AWR American States Water Company
American States Water Co is water and utilities holding company based in California. The segments of the firm include water, electric and contracted services. Within these segments, American States Water conducts water and electric operations through Golden State Water Company and Bear Valley Electric Service, Inc while contracted services through American States Utility Services and its subsidiaries. Golden State Water conducts its operations across various counties in California and is regulated by the California Public Utilities Commission. American States Utility Services has contracted with the U.S. government to provide water services to various military installations. The majority of the company's revenue is derived from water services from commercial and residential customers.